Most biosimilars are mainly available to patients as provider-administered infusions in institutional settings such as hospitals and doctors’ offices and these financial transactions generally happen outside of the PBM-retail pharmacy payment chain.
Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2024 PCMA. All Rights Reserved.